Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19

Study Overview
=================
Brief Summary
-----------------
Ivermectin is currently being utilized by a number of physicians in the local area. My objective will be to enroll these patients at the time of their evaluation for COVID-19 infection and to follow their progress through their recovery.

Detailed Description
-----------------
Patients at local physician clinics as well as my own clinic will be enrolled at the time they are evaluated for having COVID-19. Patients enrollment will be voluntary and based upon their request for treatment with Ivermectin. These patients will be questioned on symptoms and the timing of those symptoms in detail. They will then be followed throughout their treatment course to evaluate their recovery experience. Detailed accounts of their symptoms and their resolution will be followed. The study patients will stop being followed when they are either admitted to the hospital or are deemed to be symptom free. Any other medications prescribed to the patients will also be tracked. Medical histories will be taken and documented to make comparisons at the end of the study. Those patients not requesting Ivermectin will also be followed for comparisons at a later date.

Official Title
-----------------
Ivermectin Will be Used as an Outpatient Treatment Option for COVID-19 Patients.

Conditions
-----------------
Covid19, COVID-19 Pneumonia, COVID-19 Respiratory Infection, COVID-19 Acute Bronchitis

Intervention / Treatment
-----------------
* Drug: Ivermectin


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Between the ages of 12-110 years old Has a recently completed COVID test Symptomatic and seeking treatment Willingness to participate and have follow-up Able and willing to take medications and treatment suggestions from the physician Exclusion Criteria: Lack of symptoms, uncertain of COVID-19 status, outside of age limits for treatment No recent COVID test results Asymptomatic, even if COVID positive Outside of acceptable age range Meets criteria for hospital admission Unwilling to participate in trial study or have follow-up

Ages Eligible for Study
-----------------
Minimum Age: 12 Years
Maximum Age: 110 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| COVID-19 patients treated with Ivermectin<br>This group of patients will be those who requested to be treated with Ivermectin and whom have been prescribed such by different physicians. This group may or may not include those treated with Monoclonal Antibodies or Remdesivir. | Drug: Ivermectin<br>* Ivermectin treatment of outpatients dosing at 0.4mg/kg until recovered along with supplemental treatment using a multi-modal approach.<br>* Other names: Remdesivir;|
| COVID-19 patients declining Ivermectin and wanting traditional treatment<br>This group of patients will be those who do not request to be treated with Ivermerctin and who want to be treated with a more traditional, minimalist approach. This group may or may not include those treated with Monoclonal Antibodies or Remdesivir. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Complete recovery from COVID-19 with resolution of symptoms | This group recovered completely from COVID-19 and remained an outpatient throughout the duration of their illness. | 4-6 weeks per individual | 
| Admission to a hospital for further advanced treatment | This group of patients was unable to recover at home and required hospital admission | 4-6 weeks per individual |